Vyvanse is a prescription stimulant that increases levels of two chemical messengers in the brain, dopamine and norepinephrine, to improve focus, impulse control, and regulation of eating behavior. It is FDA-approved for two conditions: attention deficit hyperactivity disorder (ADHD) in people aged 6 and older, and moderate-to-severe binge eating disorder (BED) in adults.
How Vyvanse Works in the Body
Vyvanse is not active when you swallow it. It’s a prodrug, meaning it has to be converted into its working form before it does anything. After you take a capsule or chewable tablet, the medication is absorbed intact from your digestive tract. Red blood cells then break it down into its active ingredient, dextroamphetamine, plus an amino acid called lysine. Enzymes inside the red blood cells handle this conversion, though scientists haven’t pinpointed exactly which enzymes are responsible.
Once dextroamphetamine is released, it does two things in the brain: it increases the release of dopamine and norepinephrine into the spaces between nerve cells, and it blocks those chemical messengers from being pulled back in. The result is higher concentrations of both chemicals in parts of the brain responsible for attention, motivation, and impulse control. Because Vyvanse must be broken down by red blood cells first, its effects ramp up more gradually than immediate-release stimulants. Peak blood levels of the active ingredient are reached roughly 3.5 to 4.5 hours after a dose.
What It Feels Like When It’s Working
In adults with ADHD, clinical studies showed Vyvanse improved attention starting about 2 hours after a dose. In children aged 6 to 12, measurable improvements appeared within 1.5 hours. Effects lasted up to 14 hours in adults and up to 13 hours in children, which is why it’s taken once in the morning.
People typically describe the experience as feeling more “locked in” on tasks, with less mental drifting and an easier time following through on plans. Hyperactivity and impulsive behaviors tend to quiet down. In clinical trials, children taking Vyvanse were rated “very much improved” by clinicians 32% of the time, compared to just 2% on placebo. Adults saw ADHD symptom scores drop significantly starting as early as the first week of treatment, with over 84% considered improved by the end of the study period.
Vyvanse for ADHD
ADHD is the primary reason Vyvanse is prescribed. In a controlled study of children aged 6 to 12, Vyvanse at doses of 30, 50, or 70 mg significantly improved attention and behavior on every measure tested. Scores on a math performance test (used as an objective proxy for focus) jumped from an average of 88 on placebo to 133 on Vyvanse. Over a 12-month treatment period, ADHD symptom ratings improved by more than 60% from baseline.
Higher doses generally produce greater symptom improvement for both inattentive symptoms (difficulty concentrating, losing things, being easily distracted) and hyperactive-impulsive symptoms (fidgeting, interrupting, difficulty waiting). That said, individual responses vary. Baseline symptom severity and dose together only accounted for about 17% of the variation in outcomes, meaning other factors like genetics, sleep, and coexisting conditions play a large role in how well the medication works for any given person.
Vyvanse for Binge Eating Disorder
Vyvanse is the only medication FDA-approved specifically for moderate-to-severe binge eating disorder in adults. It is not approved for weight loss. In three randomized trials, doses of 50 and 70 mg per day significantly reduced the number of binge eating episodes per week. Two of the larger 12-week studies found that Vyvanse reduced weekly binge days by roughly 1.4 to 1.7 more days than placebo. The 30 mg dose did not work better than placebo for binge eating, which is why the recommended target for BED is 50 to 70 mg daily.
A pooled analysis across these trials found a large effect size for the reduction in binge days. The mechanism isn’t entirely clear, but the increase in dopamine likely helps regulate the reward-seeking and impulsive behavior that drives binge episodes.
Dosing and How It’s Prescribed
For both ADHD and binge eating disorder, the starting dose is 30 mg taken once in the morning. From there, a prescriber will typically increase the dose in increments of 10 to 20 mg per week based on how well symptoms are controlled and how tolerable the side effects are. The maximum dose for both conditions is 70 mg per day. For BED specifically, the recommended target is 50 to 70 mg daily, since lower doses didn’t outperform placebo in trials.
Common Side Effects
Vyvanse shares the side effect profile of other amphetamine-based stimulants. The most frequently reported effects in clinical trials include decreased appetite, dry mouth, difficulty sleeping, irritability, nausea, and increased heart rate. Appetite suppression tends to be the most noticeable, especially in children, and can lead to weight loss over time.
Because Vyvanse raises norepinephrine levels, it can increase blood pressure and heart rate modestly. Most people tolerate this without issues, but it’s something prescribers monitor, particularly in people with existing cardiovascular concerns. Anxiety and jitteriness can also occur, especially at higher doses or during the first few weeks of treatment.
Why It Has Lower Abuse Potential
One of the key reasons Vyvanse was designed as a prodrug is to reduce the risk of misuse. Because it has to be broken down by red blood cells before the active ingredient is released, you can’t speed up its effects by crushing, snorting, or injecting it. The drug enters the bloodstream in its inactive form regardless of how it’s taken.
Pharmacokinetic studies show that Vyvanse reaches peak blood levels more slowly and produces a lower peak concentration compared to immediate-release dextroamphetamine. These properties translate to less euphoria, which is the feeling most associated with abuse potential. Epidemiological data confirm that real-world abuse rates for Vyvanse are substantially lower than for immediate-release amphetamines. That said, it is still a Schedule II controlled substance, and some studies have found dose-dependent reinforcing effects, so the risk is reduced but not eliminated.
Vitamin C and Other Interactions
One interaction that catches many people off guard involves vitamin C. Acidic substances, including vitamin C supplements, citrus juices, and other acidifying agents, can reduce how well Vyvanse works in two ways. In the stomach, they lower absorption of the active amphetamine. In the kidneys, they make urine more acidic, which causes your body to flush out the drug faster. If you take vitamin C regularly, spacing it several hours apart from your Vyvanse dose can help avoid reduced effectiveness.
The reverse is also true: substances that make urine more alkaline (like sodium bicarbonate) can slow the clearance of amphetamines and extend their effects, which increases the risk of side effects.